| Product Code: ETC6739730 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Clinical Trial Supply & Logistics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Clinical Trial Supply & Logistics Market Revenues & Volume, 2021 & 2031F |
3.3 China Clinical Trial Supply & Logistics Market - Industry Life Cycle |
3.4 China Clinical Trial Supply & Logistics Market - Porter's Five Forces |
3.5 China Clinical Trial Supply & Logistics Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 China Clinical Trial Supply & Logistics Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.7 China Clinical Trial Supply & Logistics Market Revenues & Volume Share, By Therapeutic, 2021 & 2031F |
3.8 China Clinical Trial Supply & Logistics Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 China Clinical Trial Supply & Logistics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of clinical trials being conducted in China |
4.2.2 Growing demand for efficient and cost-effective supply chain solutions in clinical trials |
4.2.3 Advancements in healthcare infrastructure and regulatory environment in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for clinical trial logistics in China |
4.3.2 Lack of standardized processes and infrastructure for clinical trial supply chain management |
4.3.3 Limited availability of skilled professionals in clinical trial logistics sector in China |
5 China Clinical Trial Supply & Logistics Market Trends |
6 China Clinical Trial Supply & Logistics Market, By Types |
6.1 China Clinical Trial Supply & Logistics Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Logistics & Distribution, 2021- 2031F |
6.1.4 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Storage & Retention, 2021- 2031F |
6.1.5 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Packaging, Labeling, And Blinding, 2021- 2031F |
6.1.6 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Manufacturing, 2021- 2031F |
6.1.7 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Comparator Sourcing, 2021- 2031F |
6.1.8 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Other Services, 2021- 2031F |
6.2 China Clinical Trial Supply & Logistics Market, By Phase |
6.2.1 Overview and Analysis |
6.2.2 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Phase I, 2021- 2031F |
6.2.3 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Phase II, 2021- 2031F |
6.2.4 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Phase III, 2021- 2031F |
6.2.5 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.3 China Clinical Trial Supply & Logistics Market, By Therapeutic |
6.3.1 Overview and Analysis |
6.3.2 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.4 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.3.5 China Clinical Trial Supply & Logistics Market Revenues & Volume, By CNS And Mental Disorders, 2021- 2031F |
6.3.6 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Clinical Trial Supply & Logistics Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Pharmaceuticals, 2021- 2031F |
6.4.3 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Biologicals, 2021- 2031F |
6.4.4 China Clinical Trial Supply & Logistics Market Revenues & Volume, By Medical Devices, 2021- 2031F |
7 China Clinical Trial Supply & Logistics Market Import-Export Trade Statistics |
7.1 China Clinical Trial Supply & Logistics Market Export to Major Countries |
7.2 China Clinical Trial Supply & Logistics Market Imports from Major Countries |
8 China Clinical Trial Supply & Logistics Market Key Performance Indicators |
8.1 On-time delivery performance of clinical trial supplies |
8.2 Inventory turnover rate in clinical trial logistics |
8.3 Percentage of cost savings achieved in clinical trial supply chain management |
8.4 Compliance rate with regulatory requirements for clinical trial logistics |
8.5 Customer satisfaction levels with clinical trial supply and logistics services |
9 China Clinical Trial Supply & Logistics Market - Opportunity Assessment |
9.1 China Clinical Trial Supply & Logistics Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 China Clinical Trial Supply & Logistics Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.3 China Clinical Trial Supply & Logistics Market Opportunity Assessment, By Therapeutic, 2021 & 2031F |
9.4 China Clinical Trial Supply & Logistics Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 China Clinical Trial Supply & Logistics Market - Competitive Landscape |
10.1 China Clinical Trial Supply & Logistics Market Revenue Share, By Companies, 2024 |
10.2 China Clinical Trial Supply & Logistics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here